Follow NewsClips channel at Brighteon.com for more updatesSubscribe to Brighteon newsletter to get the latest news and more featured videos: https://support.brighteon.com/Subscribe.html

Follow NewsClips channel at Brighteon.com for more updatesSubscribe to Brighteon newsletter to get the latest news and more featured videos: https://support.brighteon.com/Subscribe.html

Follow NewsClips channel at Brighteon.com for more updatesSubscribe to Brighteon newsletter to get the latest news and more featured videos: https://support.brighteon.com/Subscribe.html

Wow… ? ? Man here in Australia goes to take out cash…gets rejected, then proceeds to carry on like something out of the exorcist. ????‍♂️???? While I do not support the tyrannical measures that have been introduced to our banks, I don’t feel like there’s any kind of excuse for this behaviour. I think this rightfully angry fella should have just started filming and politely asking questions to gather some evidence, rather than acting like that. Instead he has carried on like a psychotic maniac and probably got ruffed up by the police as well giving himself no leg to stand on. That’s just my take on it, but how do you feel about the video? My advice - if you're being treated unfairly then think about every action before you do it!! Please leave a comment below.... ???‍♂️?????

"Wow."

by Michael Snyder, The Economic Collapse Blog: Are you ready to pay 80 percent more for a USB-C cord?  Unfortunately, Walmart, Target and other major retailers have decided to start dramatically raising the prices of thousands of imported products.  Of course our paychecks are not going up dramatically as well, and so our standard of […]

The U.S. Food and Drug Administration (FDA) approved the Biologics License Application for the Nuvaxovid (Novavax) COVID-19 jab in adults 65 years and older and individuals 12 through 64 with at least one underlying condition. “Today’s approval solidifies a pathway for Americans aged 65 and older and those aged 12 through 64 with an underlying condition that puts them at high risk for severe outcomes from COVID-19 to have access to a protein-based, non-mRNA COVID-19 vaccine,” said John C. Jacobs, President and Chief Executive Officer, Novavax. “Market research and U.S. CDC statistics indicate that older individuals and those with underlying conditions are the populations most likely to seek out COVID-19 vaccination seasonally. This significant milestone demonstrates our commitment to these populations and is a significant step towards availability of our protein-based vaccine option,” Jacobs added. .@FDA @DrMakaryFDA how can you approve Novavax COVID-19 vaccines for elderly while knowing increased risks of Nervous system(15%),Cancers(17%), Respiratory(21%),vascular(84%),Viral(100%) and Covid-19 Infection(75%),Renal Disorders (350%) as adverse events compared to placebo?… pic.twitter.com/8Ot3yx4yC2 — VaccineMole (@VaccineMole) May 18, 2025 Per BioPharma Dive: The vaccine, which uses an older protein technology than the mRNA shots of Pfizer and Moderna, has been available in the U.S. since 2022 under emergency use authorization. While narrower, the approved indication is no more restrictive than what Leerink Partners analyst Daina Graybosch expects advisers to Centers for Disease Control and Prevention will recommend next month. In an April meeting, a panel of those advisers discussed adjusting their recommendations for COVID vaccination. News of the FDA’s approval send Novavax shares higher by double digits Monday. #NEWS: Novavax announced the U.S. Food and Drug Administration (@FDA) has approved the Company’s Biologics License Application for its COVID-19 vaccine, Nuvaxovid, triggering a Sanofi milestone payment. Read the news release: https://t.co/QqGXrhfT3Q pic.twitter.com/7misZW7snS — Novavax (@Novavax) May 19, 2025 From the Pharmacy Times: An expansion of PREVENT-19 aimed to evaluate the safety, immunogenicity, and efficacy of Nuvaxoid in 2247 adolescents aged 12 to 17 years. Investigators found that neutralizing antibody responses to Nuvaxoid were noninferior compared with those of young adults aged 18 to 25 years. Additionally, vaccine efficacy was about 79.5%, with a strong 82.0% efficacy (95% CI, 32.4%-95.2%) against the Delta variant, indicating broad protection against multiple strains of SARS-CoV-2. Reactogenicity was observed to be mild to moderate and transient in nature only, with a trend towards greater frequency following a second dose of the vaccine, according to the investigators. In addition to granting full regulatory approval, the FDA has also requested a new postmarketing commitment to conduct a phase 4 prospective, randomized, double-blinded, placebo-controlled efficacy and safety trial in individuals aged 50 through 64 without high-risk conditions for severe COVID-19. The results of this trial could lead to the expansion of the FDA’s approval for Nuvaxoid to include more patients who could benefit from protection against COVID-19.

Regeneron Pharmaceuticals said on Monday it would buy 23andMe out of bankruptcy for $256 million. The acquisition gives Regeneron the company’s genetic samples and data for millions of individuals. Regeneron Pharmaceuticals to buy 23andMe for $256M — taking control of genetic data of millions https://t.co/wh3uEsfQH7 pic.twitter.com/1bg9I6tUzi — New York Post (@nypost) May 19, 2025 From the New York Post: It will acquire 23andMe’s Personal Genome Service, Total Health and Research Services and its large biobank, including genetic data of more than 15 million customers – raising privacy concerns from individuals who had willingly handed over the samples to completely different owners. All of 23andMe’s genetic testing services will continue uninterrupted, and the deal is expected to close in the third quarter of 2025 pending bankruptcy court and regulatory approvals, Regeneron said. The Tarrytown, New York-based pharmaceutical company pledged to remain compliant with 23andMe’s consumer-privacy rules and vowed to work with a court-appointed ombudsman who will investigate the matter. “We assure 23andMe customers that we are committed to protecting the 23andMe dataset with our high standards of data privacy, security and ethical oversight and will advance its full potential to improve human health,” Aris Baras, head of Regeneron’s genetics center, said in a statement. But the pharmaceutical company will be acquiring an unprecedented collection of genetic data that has been building up since 23andMe launched its breakthrough direct-to-consumer testing in 2007. 23andMe just sold your DNA sample to Regeneron Pharmaceuticals for about $17. Bankrupt genetic-testing firm 23andMe agreed to sell its data bank, which once contained DNA samples from about 15 million people, to the drug developer Regeneron Pharmaceuticals for $256 million. pic.twitter.com/e8tgRnfZxz — Kevin Dalton (@TheKevinDalton) May 19, 2025 “We have reached a sale agreement with @Regeneron, a leading US-based biotechnology company, to carry forward 23andMe’s mission and maintain customer privacy protections,” 23andMe stated. We have reached a sale agreement with @Regeneron, a leading US-based biotechnology company, to carry forward 23andMe’s mission and maintain customer privacy protections. Read more about today’s announcement here: https://t.co/0HeAPVmWzH — 23andMe (@23andMe) May 19, 2025 Per Reuters: South San Francisco, California-based 23andMe filed for bankruptcy last month, seeking to sell its business at auction after a decline in consumer demand and a 2023 data breach that exposed sensitive genetic and personal information of millions of customers. The second-highest bid, for $146 million, was submitted by a nonprofit research institute founded by 23andMe’s former CEO and cofounder Anne Wojcicki, according to court documents. The transaction, expected to complete in the third quarter, puts the spotlight back on data privacy issues sparked off by the data breach. 23andMe, once a trailblazer in ancestry DNA testing, has also faced dwindling demand for its core services. The transaction “starts to bring about a good conclusion to what otherwise could have been a difficult bankruptcy case,” said trial attorney Daniel Gielchinsky, co-founder and partner at DGIM law. Gielchinsky said Regeneron, with its proven track record, will do a better job in the long run of protecting consumer information safeguarded by privacy laws. The hack and subsequent bankruptcy filing have drawn scrutiny from U.S. lawmakers concerned that genetic data on millions of customers could be sold to unscrupulous buyers.

BY THE OPTIMIST DAILY EDITORIAL TEAM You’re up, dressed, answering emails, maybe even making dinner — but something’s off. You feel disconnected, foggy, or emotionally flat. If that rings true, you might be experiencing what mental health professionals call a functional freeze. Unlike the more dramatic freeze response that leaves you immobilized in a moment of fear or trauma, a functional freeze is quieter and more long-lasting. You’re moving through life — but it’s on autopilot. Therapist Carly Harris, LMFT, describes it as “hitting a mental pause button.” It’s when stress or trauma sends your nervous system into a protective mode that lets you function, but only just. The good news? There are ways to recognize when you’re stuck in this state — and gentle, practical tools to help you begin thawing. Could you be in a functional freeze? Here are five signs mental health experts say to watch for: 1. Emotional numbness Feeling flat, emotionally disconnected, or distant from your reality? Harris explains this as a mental fog where decision-making and focus feel harder than usual. According to somatic therapist Marcia Bonato Warren, even when emotions surface, they may feel muted or distant. 2. Physical sluggishness You might notice a heaviness in your limbs, tension, or shallow breathing. Warren adds that some people feel extreme fatigue, slowed speech, or even digestion issues — all signs the body is in slow-down mode. 3. Foggy thinking Psychiatrist Jeffrey Ditzell, DO, notes that people in a functional freeze can seem fine from the outside but may be struggling internally with slowed processing, forgetfulness, or a vague, hard-to-pin-down mental haze. 4. Going through the motions Warren describes this as participating in daily life but feeling inwardly checked out. You might show up for your relationships or job, but feel detached, helpless, or emotionally numb while doing so. 5. Loss of motivation This state can look a lot like depression: low energy, no joy, and emotional flatness. According to Harris, prolonged stress or trauma can leave your nervous system stuck in this loop, zapping motivation and making it hard to feel much of anything. What helps: thawing out gently You can’t force your way out of functional freeze — but small steps help. Here’s where to start: Pause and ask with kindness Warren encourages starting with gentle questions, not judgment. What helps you feel grounded? Can you recognize what might have triggered your freeze? Awareness is the first sign of change. Move, breathe, notice Reconnect to the moment through your body. Harris suggests breathwork, simple movement, or naming sensory details around you. These techniques remind your system that you’re safe now. Support your basics Sleep, food, hydration, and light exercise are more powerful than they sound. Ditzell reminds us these simple routines strengthen the nervous system’s ability to reset. Name your emotions Functional freeze cuts you off from your feelings. Warren recommends gently asking: What am I feeling — or notfeeling? Are my thoughts sharp or fuzzy? Getting curious helps you tune back in. Reach out Connection is key. Talk to a friend, a therapist, or your doctor. Harris emphasizes that feeling seen and supported can signal to your nervous system that it’s safe to soften. Your next step matters Functional freeze is more than stress — it’s a nervous system response that says, “This is too much.” But you don’t have to stay there. Your body and mind want to move forward. With kindness, curiosity, and support, you can start to feel more connected again — not just functioning, but truly living.The post Feeling checked out? Here’s how to recognize functional freeze and gently move forward first appeared on The Optimist Daily: Making Solutions the News.